Pharmacokinetic (PK) Bioequivalence and Pharmacodynamics (PD) of Julphar Insulin N and Huminsulin® Basal
Status:
Completed
Trial end date:
2017-01-20
Target enrollment:
Participant gender:
Summary
This study in healthy volunteers aims to demonstrate similar PK and PD properties of the new
human isophane Insulin, Julphar Insulin N, and the already approved reference Insulin,
Huminsulin® Basal. All participants will receive both study treatments on two separate dosing
days.